Ling Geng

3.8k total citations · 1 hit paper
50 papers, 3.1k citations indexed

About

Ling Geng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ling Geng has authored 50 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 17 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Ling Geng's work include Angiogenesis and VEGF in Cancer (19 papers), Cancer, Hypoxia, and Metabolism (14 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). Ling Geng is often cited by papers focused on Angiogenesis and VEGF in Cancer (19 papers), Cancer, Hypoxia, and Metabolism (14 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). Ling Geng collaborates with scholars based in United States, China and Portugal. Ling Geng's co-authors include Dennis E. Hallahan, Allie Fu, Edwin F. Donnelly, Carolyn Cao, Jeffrey M. Albert, Gerald McMahon, Kwang Woon Kim, Kyle C. Cuneo, Jiahong Lu and Konjeti R. Sekhar and has published in prestigious journals such as Nature Medicine, Cancer Cell and Cancer Research.

In The Last Decade

Ling Geng

50 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models

2018 379 citations M. Schulte, Allie Fu et al. Nature Medicine profile →

Peers

Countries citing papers authored by Ling Geng

Since Specialization

Citations

This map shows the geographic impact of Ling Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Geng more than expected).

Fields of papers citing papers by Ling Geng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Geng. The network helps show where Ling Geng may publish in the future.

Co-authorship network of co-authors of Ling Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Geng. A scholar is included among the top collaborators of Ling Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Geng. Ling Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NK cell-derived exosomes inhibit survival of Mycobacterium tuberculosis by promoting apoptosis in mice 2024 ·Cytokine ·(unknown), Xuan Wang, Wenya Du, (unknown), (unknown), Tao Ma, (unknown), (unknown), Guofu Wang, Ling Geng, Tao Wang, (unknown)	1
2	Feasibility of [18F]FSPG PET for Early Response Assessment to Combined Blockade of EGFR and Glutamine Metabolism in Wild-Type KRAS Colorectal Cancer 2023 ·Tomography ·(unknown), Jianbo Wang, Dimitra K. Georgiou, Xiaoxia Wen, Allison S. Cohen, Ling Geng, Mohammed Noor Tantawy, H. Charles Manning	9
3	Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancer 2020 ·Translational Oncology ·Allison S. Cohen, Ling Geng, Ping Zhao, Allie Fu, M. Schulte, Ramona Graves‐Deal, M. Kay Washington, Jordan Berlin, Robert J. Coffey, H. Charles Manning	35
4	Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models breakdown → 2018 ·Nature Medicine ·M. Schulte, Allie Fu, Ping Zhao, Jun Li, Ling Geng, Shannon T. Smith, Jumpei Kondo, Robert J. Coffey, Marc O. Johnson, Jeffrey C. Rathmell, Joe T. Sharick, Melissa C. Skala, Jarrod A. Smith, Jordan Berlin, M. Kay Washington, Michael L. Nickels, H. Charles Manning	379
5	Targeting Nucleophosmin 1 Represents a Rational Strategy for Radiation Sensitization 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Konjeti R. Sekhar, Mouadh Benamar, Amudhan Venkateswaran, Soumya Sasi, Narsimha Reddy Penthala, Peter A. Crooks, Stephan Hann, Ling Geng, Ramesh Balusu, Tarek Abbas, Michael L. Freeman	28
6	The Novel Chemical Entity YTR107 Inhibits Recruitment of Nucleophosmin to Sites of DNA Damage, Suppressing Repair of DNA Double-Strand Breaks and Enhancing Radiosensitization 2011 ·Clinical Cancer Research ·Konjeti R. Sekhar, (unknown), P. Narsimha Reddy, Peter A. Crooks, Amudhan Venkateswaran, W. Hayes McDonald, Ling Geng, Soumya Sasi, (unknown), Joseph L. Roti Roti, Kenneth J. Salleng, Girish Rachakonda, Michael L. Freeman	21
7	A New Class of Molecular Targeted Radioprotectors: GSK-3β Inhibitors 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Dinesh Thotala, Ling Geng, Amy K. Dickey, Dennis E. Hallahan, Eugenia M. Yazlovitskaya	51
8	Radiation induces an antitumour immune response to mouse melanoma 2009 ·International Journal of Radiation Biology ·Carmen A. Perez, Allie Fu, Halina Onishko, Dennis E. Hallahan, Ling Geng	71
9	SU11248 (Sunitinib) Sensitizes Pancreatic Cancer to the Cytotoxic Effects of Ionizing Radiation 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Kyle C. Cuneo, Ling Geng, Allie Fu, Darren Orton, Dennis E. Hallahan, Anuradha Chakravarthy	68
10	Hedgehog signaling in the murine melanoma microenvironment 2007 ·Angiogenesis ·Ling Geng, Kyle C. Cuneo, Michael K. Cooper, Hong Wang, Konjeti R. Sekhar, Allie Fu, Dennis E. Hallahan	31
11	Effects of vascular endothelial growth factor receptor inhibitor SU5416 and prostacyclin on murine lung metastasis 2007 ·Anti-Cancer Drugs ·Kyle C. Cuneo, Allie Fu, (unknown), Ling Geng	17
12	Inhibition of Survivin and Aurora B Kinase Sensitizes Mesothelioma Cells by Enhancing Mitotic Arrests 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Kwang Woon Kim, Robert W. Mutter, Christopher D. Willey, Ty K. Subhawong, Eric T. Shinohara, Jeffrey M. Albert, Ling Geng, Carolyn Cao, Young Jin Gi, Bo Lü	29
13	Integrin αvβ3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non–small-cell lung cancer models 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Jeffrey M. Albert, Carolyn Cao, Ling Geng, (unknown), Dennis E. Hallahan, Jiahong Lu	102
14	SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiation 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Kyle C. Cuneo, Ling Geng, Jiahuai Tan, Jeffrey P. Brousal, Eric T. Shinohara, (unknown), Allie Fu, Yu Shyr, Huiyun Wu, Dennis E. Hallahan	23
15	Dynamic monitoring of LLC lung metastasis development and prevention 2005 ·Cancer Research ·Ling Geng, (unknown), Allie Fu, Dennis E. Hallahan	1
16	STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Ling Geng, Eric T. Shinohara, Dong Kim, Jiahuai Tan, (unknown), Yu Shyr, Dennis E. Hallahan	44
17	Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delay 2004 ·Journal of Controlled Release ·Ling Geng, (unknown), Konjeti R. Sekhar, Allie Fu, Dennis E. Hallahan	21
18	The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels 2004 ·Angiogenesis ·(unknown), Dennis E. Hallahan, Allie Fu, Fei Ye, Yu Shyr, Ling Geng	127
19	Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels 2003 ·Cancer Cell ·Dennis E. Hallahan, Ling Geng, Shimian Qu, Christopher Scarfone, Todd D. Giorgio, Edwin F. Donnelly, Xiang Gao, J A Clanton	110
20	Prostaglandins Protect Against Murine Hair Injury Produced by Ionizing Radiation or Doxorubicin. 1993 ·Journal of Investigative Dermatology ·Frederick D. Malkinson, Ling Geng, W Hanson	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact